Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Dec;11(12):785-9.
doi: 10.1007/s00520-003-0478-0. Epub 2003 Oct 25.

Antiemetic prescription in Italian breast cancer patients submitted to adjuvant chemotherapy

Antiemetic prescription in Italian breast cancer patients submitted to adjuvant chemotherapy

Drug Utilization Review Team in Oncology (DURTO). Support Care Cancer. 2003 Dec.

Abstract

Goal: The aim of this study was to investigate if the Multinational Association of Supportive Care in Cancer (MASCC) antiemetic guidelines for the prevention of both acute and delayed emesis induced by highly-moderately emetogenic chemotherapy were transferred in daily clinical practice in Italy 2 years after their publication.

Patients and methods: From 16 to 23 March 2000, all consecutive breast cancer patients referred to 87 Italian oncological centers to receive any cycle of adjuvant chemotherapy were monitored.

Main results: Of 715 evaluable patients submitted to chemotherapy, 533 received cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and 151 anthracyclines. Patients receiving taxanes or other experimental therapies (31) were not considered. The MASCC-recommended antiemetic prophylaxis against acute/delayed emesis was prescribed in 56.3/45.9% patients. Antiemetic prophylaxis against delayed emesis was not prescribed to 30.6% of patients. The MASCC-recommended prescription against acute emesis was more frequently followed in research centers, in Northern Italy, and in centers with experience on antiemetic research.

Conclusions: Two years after the publication of the MASCC antiemetic guidelines, strong discrepancies between these and antiemetic prescriptions in daily clinical practice in Italy were observed. The similarity of these results with those obtained in our previous drug utilization study on antiemetics, carried out before the publication of the MASCC guidelines, leads us to conclude that the transferability of antiemetic guidelines to daily clinical practice in Italy has been modest. A great effort should be made in Italy by the National Health Service to accelerate the process of implementation of antiemetic guidelines.

PubMed Disclaimer

References

    1. Ann Oncol. 2001 Aug;12(8):1059-60 - PubMed
    1. Ann Oncol. 1998 Jul;9(7):759-65 - PubMed
    1. J Clin Oncol. 1999 Sep;17(9):2971-94 - PubMed
    1. J Clin Oncol. 1997 Jan;15(1):103-9 - PubMed
    1. Ann Oncol. 1998 Aug;9(8):811-9 - PubMed

Publication types